Search

Renown Health, Nevada’s largest, not-for-profit integrated academic healthcare network, is delighted to announce Nariman Rahimzadeh, MD, FASA as the new Vice President, Medical Affairs for Renown South Meadows Medical Center, effective immediately. Dr. Rahimzadeh is a highly respected physician leader with an extensive background in medical leadership and a proven track record of enhancing patient care, driving clinical excellence and fostering a People First culture of collaboration. As part of a larger reorganization of the physician executive oversight of Renown Health’s hospitals, he will dedicate 30% of his time to this position while continuing to actively practice as an anesthesiologist. As VP of Medical Affairs, Renown South Meadows Medical Center, Dr. Rahimzadeh will collaborate with Dr. Bill Plauth, Chief Medical Officer for Renown Health, and Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine; and the yet to be filled, Vice President of Medical Affairs, Renown Regional Medical Center to support Medical and Advanced Practice Provider Staff. Together with Renown clinical and operational leaders, he will help ensure the highest standards of patient care, patient experience, and highly reliable quality and safety. Over the course of 11 years, Dr. Rahimzadeh has served as Medical Director for Surgical Services and Chief of Staff for Renown South Meadows Medical Center. Dr. Rahimzadeh will maintain his administrative and clinical responsibilities as an anesthesiologist with anesthesiology|NV. Dr. Rahimzadeh currently serves on the Board of Directors of the American Society of Anesthesiologists and is past President of the Nevada State Society of Anesthesiologists. He is a Fellow of the American Society of Anesthesiologists (FASA). A first-generation American who began his career at Renown (then Washoe Medical Center) as a shuttle bus driver, Dr. Rahimzadeh completed his bachelor’s degree in Pre-Medicine at the University of Nevada-Reno and is a graduate of Ross University School of Medicine in Florida. He completed two residency programs at the University of Connecticut in both Anesthesiology and Internal Medicine. He returned home to Reno as a private practice anesthesiologist in 2007. Renown Health and northern Nevada are undergoing a period of tremendous growth. Renown plays an essential role as the only locally governed, not-for-profit charitable healthcare network for the region. Dr. Rahimzadeh’s promotion to VP of Medical Affairs for South Meadows Medical Center underscores an ongoing commitment to advancing high-quality care and service to patients and to strategic growth and partnerships. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Renown Health Announces Nariman Rahimzadeh, MD, FASA as Vice President, Medical Affairs for South Meadows

Justin Coran, PhD, MPH, Chief Analytics Officer of Renown Health, Reno’s only not-for-profit, charitable health care network, is one of 100 senior leaders in data science to be nationally recognized, and the only expert from Nevada to win an AI100 Award celebrating the achievements of those making significant advancements in the field of Analytics, Data Science & AI. “These leaders demonstrate leadership in the development and deployment of AI technologies in their industry, innovative thinking and contributions that have advanced the field of Analytics and have a track record of measurable impact with their teams, such as improved business outcomes, increased efficiency, and improved quality of life for customers,” AIM stated.  Dr. Coran was named one of four “Data Driven CxOs” on AIM Research's list of the 100 most influential artificial intelligence leaders in the U.S. for 2024 at an in-person ceremony on July 26 at MachineCon USA in NYC.  “We are so pleased that Dr. Coran and his team have been nationally recognized at being at the forefront of data science and technology,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “Over the last year, Justin has built a high-performing team and created a supportive environment that has improved business operations and patient care. Justin’s dedication to improving the reliability, integrity and accuracy of data is inspiring teams to achieve significant results that have benefited many. Justin is a dedicated leader and is well deserving of this recognition. We are very proud of his accomplishments and thank him and his team for all they do for Renown and our patients.” Dr. Justin Coran is a data scientist and applied medical sociologist with over twenty years of experience in health care reporting systems, advanced analytic product development that assists with medical decision-making, culturally competent non-biased medical care, physician-patient interaction, and healthcare quality. Dr. Coran joined Renown Health in 2023 as Chief Analytics Officer and was appointed as an adjunct professor for the University of Reno School of Medicine. Leading a division of nearly 60 professionals, Dr. Coran is responsible for creating the strategy and vision for data engineering, data analytics, and data science. He completed his graduate training at the University of Florida where he received his Doctoral degree in medical sociology and Master of Public Health degree in hospital administration and epidemiology.  Dr. Coran says, "Care teams need accurate and timely information to make decisions that directly impact patients. With a reliable system to analyze and deliver complex data, improvements and impactful changes can be made every day. This is where the power of a data and analytics team comes into play.” As lead for Renown Health’s Enterprise Data & Analytics (EDA) department, Dr. Coran and his team are leaders of this transformation. This team cares for Renown’s caregivers by delivering key data and insights with thorough analytics. Their data-driven approach ensures the organization is moving towards consistent progress and excellence in patient care, creating a better healthcare experience for all.  According to Justin and his team, every day brings a blend of exploration, engagement and discovery. Their role within the health system is central to turning data into useful ideas that drive meaningful change for all.    Justin Coran is a member of the leadership team at Renown Health. Renown Health is listed as Forbes' Best Healthcare Employer in Nevada. As the region’s only Level 2 Trauma Center for adults and children, Renown serves over 1 million people and 100,000 square miles. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada for 2024, 2023 and 2022.  Read more here. Renown Health is hiring exceptional professionals and offers a culture of dignity and respect with opportunities for flexibility and growth. As a national health leader, Renown provides access to state-of-the-art technologies, advanced facilities, and integrated patient systems. For more information, visit renown.org/careers.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Reno Home to Analytics and Data Science Expert of The Year

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

Renown Health just announced a new, digital tool designed to keep our community safe and healthy. Symptom Checker, which launched today, is a user-friendly, web-based platform that assesses patients’ symptoms and seamlessly directs them to the appropriate level of care within the Renown network. Symptom Checker can be accessed 24/7 by visiting Renown Symptom Checker. From there, a patient can identify the area of the body responsible for their discomfort, and specify their symptoms. Upon entering their symptoms, patients receive a detailed health summary and care guide, which helps them determine the most appropriate action to take. Patients are able to schedule a visit at a Renown location directly through the Symptom Checker portal. Patients experiencing a medical emergency should not use Symptom Checker and instead call 911. “Thanks to Symptom Checker, our patients will have around-the-clock support at their fingertips to help them make informed decisions about their healthcare needs,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We understand that determining the right level of care for you or your loved ones may bring about some uncertainty, which is why we are proud to continuously offer new and innovative technologies that make it easier for our community members to live healthier lives.” “As we continue experiencing cases of COVID-19 in Washoe County, many individuals with COVID are unsure when they should seek medical care, as well as the appropriate location to receive care,” said Melodie Osborn, RN, Chief Quality and Nursing Officer, Health Services. “With Symptom Checker, people can easily input their symptoms, and include the symptom severity, to be directed to the best level of care for their individual health needs—making it an extremely valuable tool as we fight to keep our community safe and healthy amidst this pandemic.” Symptom Checker is free to use and does not require users to be Renown patients. In addition to nearly 200 children and adult symptom care guides, the platform also features 55 first-aid topics, 147 parenting advice topics, and 25 over-the-counter drug dosage tables for children and adults. The Symptom Checker content is written by medical doctors, Barton Schmitt and David Thompson, who are nursing triage experts; and symptom care guides stem from clinical protocols used by doctors and nurses worldwide. Evidence behind the Symptom Checker can be accessed here. For more information, or to use Symptom Checker, please visit Renown Symptom Checker.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Launches Virtual Symptom Checker

Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental and social data) started notifying consenting study participants who have certain genetic variants which predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease relevant to their underlying genetic condition. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Learn more at www.helix.com.

Read More About Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Members of the media are invited to meet DANA this morning from 10 a.m. – noon. Please reply to this email or call (775) 691-7308 to coordinate a meet and greet. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” With more than 51,000 study participants enrolled to date, the Healthy Nevada Project® is considered the fastest-enrolling genetic study in the country. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Read More About Introducing Dana Renown Institute for Health Innovations New Life Sized Holographic Kiosk

Through the COVID-19 pandemic, Renown providers remain committed to safely caring for community members, both in person and virtually. Renown Health is proud to offer same-day virtual visits to help community members maintain their health and address medical concerns amid the COVID-19 crisis and beyond. Virtual Visits are easily-accessible video conferencing visits with a health provider. They are used for primary care, specialty care and urgent care to enable patients to consult a care provider from the ease and comfort of their homes. “If there’s a bright spot in the midst of this pandemic, it’s that COVID-19 is pushing us to rapidly adopt new ways of thinking about and delivering healthcare–through new technologies,” said Dr. Tony Slonim, president and CEO of Renown. “Our team has worked diligently to make virtual visits available to our community as an added convenience for those who would prefer to stay in their homes. As we work to keep all of our patients safe and healthy, we want our community to know we’re here to serve any ongoing healthcare needs they have by expanding our care options.” Virtual Visits for Urgent Care For urgent care needs, individuals can log in to MyChart and request to “Talk to a Doctor” to receive care from a Renown provider. After filling in some information and confirming their healthcare concerns, Renown’s healthcare team will notify them by text or email when a provider is ready to talk to them virtually. Providers will help patients determine whether their health needs can be met from their home or if they need to seek in-person care. Virtual urgent care visits can address the following symptoms: Common cold and cough symptoms Muscular, tendon or joint pains not caused by injury Allergy or sinus symptoms Pink eye Urinary discomfort Diarrhea without vomiting Rashes or skin sores Backache Nail problems Screening examination for sexually transmitted illness (without symptoms) Medication refills (not controlled substances) Renown’s urgent care virtual visits are available 8:30 a.m. through 10:30 p.m. Monday-Friday and 9:30 a.m. to 4:30 p.m. Saturday and Sunday. Virtual Visits for Primary Care and Specialty Care Many primary and specialty care appointments for adults and children are now available virtually through Renown Medical Group. Individuals with an existing Renown Medical Group provider are encouraged to call 775-982-5000 if they would prefer to see a provider from  home. Home Medical Visits Last week, Renown announced its partnership with DispatchHealth, which is now making house calls to individuals who prefer to be seen from their home by a licensed medical professional. This high-quality medical care option is available to all Reno/Sparks residents, both insured and uninsured. If a patient is uninsured, there is a flat fee of $275, which includes all medications administered and lab tests on site. “Whether a patient prefers to be treated at home or in one of our traditional office settings, we are prepared to provide the right level of care, at the right place, at the right time,” said Dr. Slonim. “From routine exams and checkups to illnesses and other conditions that may arise, it’s critical to continue seeing to your unique healthcare needs.” All virtual visits require a free MyChart account. Those who do not have a MyChart account can sign up online. Most insurance companies apply the same co-pay fees as charged for in- person visits. For more information on virtual visits, please visit https://www.renown.org/explore/virtual-visits/.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Receive Care From the Comfort of Your Couch: Renown Health Offering Virtual Visits

“Amazing! Phenomenal! Thank you for always showing genuine concern. You are kind, considerate and caring. You are interested in me. You are the best doctor I have ever had. I trust you with my life. You act on things, right away. You are awesome. You have saved my life, and my family. You are knowledgeable, thorough, intelligent and compassionate. You are my favorite. You are my angel baby. You have made me better. You always make me feel like a success, even if I could have tried harder. I love you. I thank you.” These are some of the comments made by patients regarding their doctors and advanced practice providers honored this morning by Sy Johnson, President and Chief of Staff for Renown Health. In honor of Healthcare Week, Renown Medical Group, the largest medical practice in northern Nevada, honored 46 physicians and advanced practice providers at the Dr. John Spellman Excellence in Patient Communications Award Celebration. This new annual award, supported by the Renown Health Foundation charitable organization and a donor family, honors physicians and advanced practice providers who demonstrate exceptional communications skills in their clinical practice, as awarded by their patients. Recipients of this award are ranked in the top ten percent nationally in provider communication for 2021, as measured by over 11 thousand patients who responded to the Centers for Medicare & Medicaid Services’ (CG-CAPHS) or Clinician and Group Consumer Assessment of Healthcare Providers and Systems patient experience survey between October 2020 and June 2021. Patients were asked if their medical providers explained things in a way they could understand; if they listened carefully; if they showed respect for what they had to say; if they spent enough time with them; if they read their medical records; if they ordered tests and followed up with them on their results; and to give them a rating on a scale of 1 to 10, where 10 was the highest score. “As honorees, your patients have given you a 10, an A+ and you set the gold standard for excellent communications with patients-scoring in the top 10% nationally,” said Rahul Mediwala, MD, Chief Medical Officer for Renown Medical Group. “I love what I do, and it’s wonderful to know that my patients appreciate the care I provide,” said Christina Alsop, DNP, one of the providers honored today. The awards were given in remembrance of Dr. John W. Spellman, human rights advocate, scholar and professor, 7/27/1934 to 6/25/2021 by his family. The Recipients of the 2021 Dr. John Spellman Excellence in Patient Communications Award are: Alsop, Christina Barangan, Caroline J. Basho, Shruti Bloch, Melissa P Bryan, Janice K. Budhecha, Sonia Burgio, Pamela A. Cavin, Lisa C. Dimpel, Ashley J. Dorsa, Denise J. Galanopoulos, Christos A. Galdo, Bella B. Grudzinski, Courtney Dianne Hansen, Benjamin Hardacre, Michael C. Healy, Sara Anne Kermode, Charlotte A. Kiser, Michele J. Klippenstein, Matthew Landis, Philip H. May, Whitney Medina, Mary Beth E. Mindeguia, Catherine E. Miyagawa, Dean Moore, Willa F. Morris, Katelyn Morton, Lillian Nielsen, Lorri Nylk, Janina Park, Susan J. Patel, Bejal Powers, Cindy M. Roumanas, Athan Safdi, Adam Sandefur, Lauren L. Schnell Blitstein, Jamie M. Silverhart, Julie A. Stodtmeister, Russell T. Sutton, Jennifer B. Tay, Jennifer Thyssen, Katherine A. Wagner, Karen Wiese, Matthew C. Wilson, Kristin L, Zucker, Jacob P. Patients served include those at Renown Regional Medical Center, the only Level II Trauma Center between Sacramento and Salt Lake City, and #1 Hospital in the State of Nevada in U.S. News and World Report Best Hospital Rankings for 2021. Physicians and providers also provide services to patients at Renown South Meadows Medical Center, named #1 Best Hospital for 2020 by U.S. News & World Report; and to patients at RenownRehabilitation Hospital, northern Nevada’s only Commission on Accreditation of Rehabilitation Facilities (CARF)- accredited hospital, specializing in the treatment of brain injury, spinal cord injury and stroke. Renown Health is integrated with the University of Nevada, Reno School of Medicine, Nevada’s first medical school, which serves to enhance the health of the community through increased access to care, innovative health care delivery, expansion of clinical research and training for the next generation of physicians and health care professionals. Almost 700 Renown Medical Group primary care and specialty providers are currently accepting new patients and accept most health insurance plans, including Renown’s not-for-profit insurance plan, Hometown Health. To find the doctor or provider that is best for you visit renown.org, or self schedule with your established provider at MyChart or call the Renown Customer Engagement Center at 775-982-4100. Renown Health is currently hiring in all areas. Search for a new career opportunity and apply online at careers.renown.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Honoring Excellence in Patient Communications

The award is given annually to a member of the Nevada pharmacy community making significant and sustained contributions to the field Kate Ward, Pharm.D., BCPS Director of Clinical Pharmacy at Renown Health is the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. Dr. Ward has been with Renown for over a decade, starting as a Clinical Pharmacist in 2009. As the Director of Clinical Pharmacy, she is responsible for the oversight of all clinical pharmacy activities at Renown Regional, South Meadows and Rehab. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown Regional Medical Center. “We are so proud that Kate has been recognized by the Nevada Society of Health System Pharmacists with the President’s Award and for her many accomplishments as a member of our Renown Pharmacy team. With 66% of adults taking five or more drugs per day and 27% taking 10 or more per day, a pharmacist’s review is critical in supporting patient safety and well-being,” says Tom Graf, MD, interim CEO, Renown Health. “Beyond that, pharmacists have the ability to suggest methods for accurately and effectively taking prescribed medications, discuss medication safety, identify and manage side effects and assist patients and families in managing chronic health conditions.” As a licensed pharmacist, Dr. Ward holds The Doctor of Pharmacy degree (abbreviated Pharm.D. or PharmD) from the University of Colorado. The Pharm.D. is a professional degree similar to a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists. The Doctor of Pharmacy degree takes three to four years of undergraduate pre-professional (prerequisite) coursework, followed by four academic years in a professional program. Most students need four years to complete their prerequisite courses. Thus, it usually takes eight years of college study to earn a Pharm.D. and become a pharmacist. Pharmacists working in hospitals and health systems often complete additional post-graduate training after a Pharm.D. degree. Dr. Ward completed a PGY1 Residency at Stanford prior to joining the Pharmacy Department at Renown. “Dr. Ward is such an asset to Renown and our community. Her incredible perseverance to reach for and achieve higher aspirations has resulted in this important recognition by our peers across the state. She consistently contributes her pharmacy expertise to patients, physicians, clinicians and healthcare students and volunteers her time to advance the profession at both the state and national level through pharmacy professional organization participation. It is wonderful to have her efforts recognized by NVSHP,” says Adam Porath, Pharm.D., BCACP, BCPS, FASHP, Vice President, Pharmacy. On Sept. 24, NVSHP and the Nevada Pharmacy Alliance held their annual joint meeting at Renown Regional Medical Center. During this meeting, Dr. Ward was awarded the NVSHP President’s Award. The President’s Award is awarded annually at NVSHP President's discretion to a member making significant and sustained contributions to NVSHP. Dr. Ward was specifically recognized for representing the State of Nevada at the American Society Health System Pharmacists House of Delegates for several consecutive years, as well as her continuous contributions to the annual NVSHP Student Symposium. Established in October 2006, NVSHP has diligently worked on continuing the strong foundation developed to better meet the needs of health-system pharmacists in Nevada. The organization was established on a strong mission statement that enables Nevada's pharmacists to be heard, from all regions of the state and in one collective voice to advocate for patient care. Are you interested in working with this award-winning team? The Renown Health Pharmacy is hiring for multiple roles, including pharmacy technician and clinical pharmacist. For more information, visit careers.renown.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Read More About Renown's Dr. Kate Ward Honored with Nevada Society of Health System Pharmacists (NVSHP) President's Award

Renown Health team recognized nationally for excellence in health care communications and outreach. Each year, Ragan Communications and PR Daily celebrate the most successful teams in the communication, public relations, marketing and employee wellbeing industries. As the leading voice in organizational communications – both internal and external – Ragan Communications recognizes the industry’s best communications teams. This prestigious award recognizes professional excellence while inspiring and engaging other current and future communicators regarding best practices. This year, Ragan Communications and PR Daily have selected the Marketing, Communications, Patient Experience and Community Outreach Team for Renown Health as “Communications Team of the Year.” In selecting Renown Health for this honor, Ragan judges noted that Renown Health earned its spot as a “Communications Team of the Year” for their communications response to the COVID-19 pandemic and for engaging the community to build a high-quality, trusted and desired health care experience, brand and reputation. Specifically the judged noted that Renown “implemented a Health Incident Command Structure to serve the community, organizing communications resources to mitigate, prepare, respond, communicate and recover from the COVID-19 outbreak and enhancing Renown ‘s capacity to provide access to care. The Renown team also implemented a plan to communicate safety, and prevention messaging, creating and distributing timely, accurate, and relevant communications customized to audience needs to reduce anxiety and maintain Renown’s leadership position for patient safety.” Judges also noted the success of the inspirational brand and messages of the “Fight the Good Fight” campaign, which helped to inspire and motivate a community through a difficult time. Through the pandemic, the Communications team also successfully implemented a new website, renown.org. Over 2.2 million people a year now visit the site to find a doctor by reading honest reviews from certified patients for Renown Medical Group providers, enroll for Hometown Health insurance benefits or seek health information or care. The Renown Health Marketing, Communications, Patient Experience and Community Outreach Team is led by Suzanne Hendery, Cristal Herrera, Emily MacMillan, Whitney Hansen and Annie Zucker and represent professionals with research, digital, web, communications, marketing, outreach, customer service and relationship-building expertise. The team was selected as one of three health care organizations and amid a flood of impressive entrants from all industries including Twitter and 3M. Commenting on the team, Thomas Graf, MD, FAAFP, CEO of Renown Health said, “We are very proud that Renown Health has been honored for excellence in communications. Improving the health and wellness of an entire population of people is a huge task- and it takes all of us, working together, to accomplish great things. We focus on preventing illnesses, and we benefit from a team of professional communicators who believe in- and demonstrate our mission- to keep people healthy, to make healthcare more accessible and affordable, and to achieve the vision of a healthy Nevada.” Renown Health is hiring key roles to support the health and well-being of our community, and encourages those with a passion for service to join the Renown family to Fight the Good Fight. Apply at careers.renown.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

Read More About Renown Home to "Communications Team of the Year"